Chouhan, Manil D. http://orcid.org/0000-0001-5903-1002
Fitzke, Heather E.
Bainbridge, Alan
Atkinson, David
Halligan, Steve
Davies, Nathan
Lythgoe, Mark F.
Mookerjee, Rajeshwar P.
Menys, Alex
Taylor, Stuart A.
Funding for this research was provided by:
Wellcome Trust (WT092186)
UCLH Biomedical Research Centre
Article History
Received: 5 March 2021
Revised: 3 June 2021
Accepted: 5 June 2021
First Online: 20 June 2021
Declarations
:
: Manil D Chouhan—no relevant conflict of interest or competing interest to declare. Heather E Fitzke—BBBSRC funded work placements with Motilent Ltd in 2018 and 2020 (BB/S508019/1). No other relevant conflict of interest or competing interest to declare. Alan Bainbridge, David Atkinson, Steve Halligan, Nathan Davies, Mark F Lythgoe, Rajeshwar P Mookerjee have no relevant conflict of interest or competing interest to declare. Alex Menys—is the CEO of Motilent. No other relevant conflict of interest or competing interest to declare. Stuart A Taylor—has share options in Motilent and is a consultant at Alimentiv. No other relevant conflict of interest or competing interest to declare.
: Preclinical-approval obtained from the Animal Care Ethical Committee of University College London.Clinical-Research Ethics Committee (Joint RNOH/IOMS, Reference Number 08/H0724/35) approval was obtained.
: Written consent obtained from all clinical study participants.
: Written consent obtained from all clinical study participants, with implied consent from all authors.